… of apixaban, dabigatran, edoxaban and rivaroxaban, each … the risk of ICH, stroke/SE and
major bleeding versus warfarin.… - and low-dose rivaroxaban in Asians with atrial fibrillation. J Am …

… of dabigatran and rivaroxaban versus warfarin using data … present study, a much lower risk
associated with dabigatran … that dabigatran had a lower major bleeding rate than warfarin …

… -inferiority of low-dose rivaroxaban compared with warfarin was … incidence of gastrointestinal
hemorrhage in our rivaroxaban cohort. … Third, our study did not include apixaban. Although …

… hemorrhage than warfarin, while rivaroxaban and apixaban … had 30% lower risk for major
bleeding events occurrence … Management of newly detected atrial fibrillation: a clinical practice …

… similar rate of bleeding events in patients with non-valvular AF and have replaced … patients
in the NOACs group were prescribed dabigatran (N = 581), rivaroxaban (N = 923), apixaban …

… claims data from acute care hospitals in Japan. Although … ; were taking warfarin, apixaban,
dabigatran, rivaroxaban, or … on the index date; had major bleeding, stroke/SE, or transient …

… In reality, an RCT in Japan demonstrated that rivaroxaban at a … at least one inpatient
claim/two outpatient claims with a … No OACs (apixaban/dabigatran/rivaroxaban/warfarin) should …

… similarly to the matching of a DOAC user to a warfarin user, except … (dabigatran, rivaroxaban,
apixaban, and edoxaban) as a … patient-years in warfarin users without a history of bleeding …

… in the risk of MB when comparing low dose dabigatran to … apixaban and rivaroxaban were
associated with a lower risk of stroke/SE, and dabigatran was associated with a similar risk of …

… the risk of stroke/systemic embolism (S/SE) and major bleeding (MB) between … risk of S/SE
was lower in patients treated with 5 mg apixaban, 15 mg rivaroxaban, or 220 mg dabigatran …